Literature DB >> 2578891

Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation.

S M Thacher, R H Rice.   

Abstract

The predominant form of the cross-linking enzyme, transglutaminase, in cultured normal human epidermal keratinocytes, is found in cell particulate material and can be solubilized by nonionic detergent. It elutes as a single peak upon either anion-exchange or gel-filtration chromatography. Monoclonal antibodies raised to the particulate enzyme cross-react with one of two transglutaminases in the cell cytosol. The second cytosolic transglutaminase, which has distinct kinetic and physical properties from the first, does not cross-react and is not essential for formation of the keratinocyte cross-linked envelope in vitro. The anti-transglutaminase antibodies stain the more differentiated layers of epidermis in a pattern similar to that given by anti-involucrin antiserum. These observations support the hypothesis that the transglutaminase so identified is involved in cross-linked envelope formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578891     DOI: 10.1016/0092-8674(85)90217-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  84 in total

1.  Proteomic analysis of hair shaft and nail plate.

Authors:  Robert H Rice
Journal:  J Cosmet Sci       Date:  2011 Mar-Apr       Impact factor: 0.948

2.  In vitro development and characterization of a manatee bronchial cell line.

Authors:  James M Sweat; Calvin M Johnson; E Paul J Gibbs
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

3.  Serial cultivation of normal human keratinocytes: a defined system for studying the regulation of growth and differentiation.

Authors:  E W Johnson; S F Meunier; C J Roy; N L Parenteau
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

4.  Organization and evolution of the human epidermal keratinocyte transglutaminase I gene.

Authors:  R R Polakowska; T Eickbush; V Falciano; F Razvi; L A Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Cornifin, a cross-linked envelope precursor in keratinocytes that is down-regulated by retinoids.

Authors:  K W Marvin; M D George; W Fujimoto; N A Saunders; S H Bernacki; A M Jetten
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

6.  Type I transglutaminase accumulation in the endoplasmic reticulum may be an underlying cause of autosomal recessive congenital ichthyosis.

Authors:  Haibing Jiang; Ralph Jans; Wen Xu; Ellen A Rorke; Chen-Yong Lin; Ya-Wen Chen; Shengyun Fang; Yongwang Zhong; Richard L Eckert
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

7.  "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Authors:  M Piacentini; F Autuori; L Dini; M G Farrace; L Ghibelli; L Piredda; L Fesus
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

8.  Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C.

Authors:  M Ohba; K Ishino; M Kashiwagi; S Kawabe; K Chida; N H Huh; T Kuroki
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.

Authors:  G D'Argenio; M Calvani; N Della Valle; V Cosenza; G Di Matteo; P Giorgio; S Margarucci; O Petillo; F P Jori; U Galderisi; G Peluso
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

10.  Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures.

Authors:  Saskia Lippens; Mark Kockx; Geertrui Denecker; Michiel Knaapen; An Verheyen; Ruben Christiaen; Erwin Tschachler; Peter Vandenabeele; Wim Declercq
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.